Congenital Hypothyroidism in Pediatrics: High-Yield | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes [ Medical Education ](https://mdster.com/blog?category=medical-education) Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes =============================================================== A high-yield pediatric approach to newborn screen detection, why treatment cannot wait, and how follow-up protects neurodevelopment [ MDster Editorial Team ](https://mdster.com/about) · Apr 04, 2026 · 6 min read · 165 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ Endocrinology ](https://mdster.com/blog?tag=endocrinology) [ Newborn Screening ](https://mdster.com/blog?tag=newborn-screening) [ Thyroid Disorders ](https://mdster.com/blog?tag=thyroid-disorders) ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg) Share this article Share this post On this page 1. [ Newborn screen detection: trust the system, but know its blind spots ](#newborn-screen-detection-trust-the-system-but-know-its-blind-spots) 2. [ Levothyroxine is urgent, not elective ](#levothyroxine-is-urgent-not-elective) 3. [ Monitoring is where outcomes are won or lost ](#monitoring-is-where-outcomes-are-won-or-lost) 4. [ Developmental outcomes: reassuring, but only if you earn them ](#developmental-outcomes-reassuring-but-only-if-you-earn-them) 5. [ Clinical Correlations ](#clinical-correlations) 6. [ Key Takeaways ](#key-takeaways) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) On this page 1. [ Newborn screen detection: trust the system, but know its blind spots ](#newborn-screen-detection-trust-the-system-but-know-its-blind-spots) 2. [ Levothyroxine is urgent, not elective ](#levothyroxine-is-urgent-not-elective) 3. [ Monitoring is where outcomes are won or lost ](#monitoring-is-where-outcomes-are-won-or-lost) 4. [ Developmental outcomes: reassuring, but only if you earn them ](#developmental-outcomes-reassuring-but-only-if-you-earn-them) 5. [ Clinical Correlations ](#clinical-correlations) 6. [ Key Takeaways ](#key-takeaways) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) The dangerous part of **congenital hypothyroidism (CH)** is that the newborn often looks well. Maybe there is mild jaundice, sleepy feeding, or nothing at all. Meanwhile, untreated hypothyroidism is injuring a hormone-dependent brain. That is why CH remains a boards favorite: it is one of the few pediatric endocrine diagnoses where screening, rapid confirmation, and immediate treatment clearly change developmental outcome. [\[1\]](#cite-1 "Reference [1]") Newborn screen detection: trust the system, but know its blind spots -------------------------------------------------------------------- In the United States, CH is routinely detected by dried blood spot newborn screening from a heel stick, usually collected around **24 to 48 hours after birth**. Collection before 24 hours can mislead because of the physiologic postnatal TSH surge. Programs do not all use the same strategy: some are **primary TSH**, some **primary T4 with backup TSH**, and some combine both. So, know your local lab algorithm. Most importantly, an abnormal screen is **not** the diagnosis; send **serum TSH and free T4** promptly. [\[2\]](#cite-2 "Reference [2]") Board pitfall: a normal first screen does **not** end the story in a high-risk infant. Preterm and VLBW infants, babies with Down syndrome, same-sex twins of an affected infant, and infants exposed to dopamine are at higher risk for delayed TSH rise or false-negative initial screening. If the baby has prolonged jaundice, hypoglycemia, macroglossia, large fontanelles, poor feeding, or pituitary red flags, check serum thyroid studies even if the newborn screen was reported as normal. [\[3\]](#cite-3 "Reference [3]") SituationWhy it mattersPreterm/VLBW infant, Down syndrome, same-sex twin of an affected infantHigher risk of delayed TSH elevation; repeat screening around **10 to 14 days** is recommended. [\[3\]](#cite-3 "Reference [3]")Symptomatic infant with a “normal” screenCentral CH and late-evolving primary CH can be missed; send **serum TSH and free T4**. [\[4\]](#cite-4 "Reference [4]") Levothyroxine is urgent, not elective ------------------------------------- Treat suspected CH like a **medical emergency**. Discuss with pediatric endocrinology the same day, draw confirmatory serum tests, and start **levothyroxine (LT4)** immediately when the labs support the diagnosis—**definitely within 2 weeks of birth**. Do **not** wait for thyroid ultrasound or scintigraphy. Imaging helps with etiology, but it must never delay hormone replacement. Current guidance supports treatment when free T4 is low with elevated TSH, when **TSH is >20 mU/L** even if free T4 is normal, and when **TSH remains >6 mU/L beyond 21 days**. [\[4\]](#cite-4 "Reference [4]") Start with **10 to 15 mcg/kg/day** once daily; use the higher end in severe disease. In a term infant, that usually means **37.5 or 50 mcg daily**. Give crushed tablets in a small amount of water. Avoid casual mixing with soy, iron, or calcium-heavy feeds that impair absorption. Boards love the trap of undertreating because the dose “feels high.” In CH, the initial dose is supposed to be aggressive because rapid biochemical correction is part of neuroprotection. [\[4\]](#cite-4 "Reference [4]") > **Clinical Pearl:** If you are choosing between getting the thyroid scan today and getting the first LT4 dose today, choose the hormone. Imaging can wait; the brain cannot. [\[4\]](#cite-4 "Reference [4]") Monitoring is where outcomes are won or lost -------------------------------------------- Starting therapy is only half the job. During the first 3 years of life, aim to keep **free T4 or total T4 in the upper half of the age-specific reference range** while bringing TSH into the normal range. If T4 has not reached that upper half within 2 weeks, or TSH has not fallen below 20 mU/L within 4 weeks, think systematically: missed doses, wrong administration, malabsorption, or underdosing. Do not “watch and wait” through abnormal infancy labs. [\[5\]](#cite-5 "Reference [5]") A practical high-yield schedule is this: recheck at **2 and 4 weeks** after treatment starts, then **every 1 to 2 months during the first year**, **every 2 to 3 months from 1 to 3 years**, and again about **2 weeks after any dose change**. At follow-up, do more than read numbers. Review how the family gives the medication, plot growth carefully, and keep hearing and developmental surveillance active. Overtreatment is not benign; it has been associated with **craniosynostosis** and abnormal brain and bone maturation. [\[5\]](#cite-5 "Reference [5]") Developmental outcomes: reassuring, but only if you earn them ------------------------------------------------------------- Modern outcomes are good. In the **vast majority** of infants detected early and treated adequately, growth, school performance, and overall neurodevelopment are normal, and severe intellectual disability has largely disappeared. Even infants with severe CH can reach normal IQ when treatment starts very early and at an adequate dose. [\[6\]](#cite-6 "Reference [6]") The children who still do poorly are usually the ones who are **missed**, **treated late**, or **poorly controlled** in infancy. That is why developmental follow-up is not optional paperwork. If the cause is not clearly permanent, re-evaluate after **age 3 years** by stopping LT4 for **4 to 6 weeks** and repeating thyroid function tests. Do not label a child “lifelong hypothyroid” without proving it. [\[1\]](#cite-1 "Reference [1]") Clinical Correlations --------------------- On rounds, remember three rules. First, never let a normal newborn screen overrule a concerning exam in a preterm or syndromic infant. Second, never delay LT4 for imaging. Third, never accept “borderline” confirmatory labs without a plan: either treat, or repeat **serum TSH and free T4 within 1 to 2 weeks**. Those are exactly the errors that turn a screen-detected disease into a delayed diagnosis. [\[1\]](#cite-1 "Reference [1]") Key Takeaways ------------- - Most infants with CH are clinically subtle; the **newborn screen** is what saves neurodevelopment. [\[7\]](#cite-7 "Reference [7]") - An abnormal screen requires **serum TSH and free T4**, not reassurance and not delay. [\[3\]](#cite-3 "Reference [3]") - Start **levothyroxine 10 to 15 mcg/kg/day** promptly and **within 2 weeks of birth**. [\[4\]](#cite-4 "Reference [4]") - Monitor aggressively in the first 3 years and target **T4 in the upper half of normal**. [\[5\]](#cite-5 "Reference [5]") - If permanent disease is not established, reassess after **age 3 years** with a supervised trial off therapy. [\[1\]](#cite-1 "Reference [1]") Conclusion ---------- Congenital hypothyroidism is one of Pediatrics’ clearest examples of why systems matter: screening finds it, but **timely LT4 and disciplined follow-up** are what protect the child. For boards and for practice, think fast, treat early, and monitor like the brain depends on it—because it does. [\[1\]](#cite-1 "Reference [1]") Frequently Asked Questions ---------------------------- ### Should I wait for thyroid imaging before starting levothyroxine? No. Draw confirmatory serum **TSH** and **free T4**, but do not delay treatment for ultrasound or scintigraphy if CH is biochemically supported. ### Which infants need repeat screening despite a normal first newborn screen? Think about repeat screening in **preterm/VLBW infants**, infants with **Down syndrome**, and **same-sex twins** of an affected infant; delayed TSH rise is a classic pitfall. ### What is the usual starting dose of levothyroxine in congenital hypothyroidism? Start **LT4 10 to 15 mcg/kg/day once daily**. Use the higher end for more severe disease. ### What lab pattern should I target during early treatment? Aim for **free T4 or total T4 in the upper half of the age-specific reference range** and a normalizing **TSH**. ### When can I test whether hypothyroidism is transient rather than permanent? If permanence is not already established, reassess after **3 years of age** with a supervised trial off levothyroxine, usually for **4 to 6 weeks**, followed by repeat thyroid function testing. References (10) ------------------- 1. 1. [ Rose SR, et al. Congenital Hypothyroidism: Screening and Management. Pediatrics. 2022. ](https://publications.aap.org/pediatrics/article/151/1/e2022060420/190308/Congenital-Hypothyroidism-Screening-and-Management) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ newbornscreening.hrsa.gov/newborn-screening-process ](https://newbornscreening.hrsa.gov/newborn-screening-process) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2021/vol-14-issue-3-p-5-6 ](https://www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2021/vol-14-issue-3-p-5-6/) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ pedsendo.org/wp-content/uploads/2020/09/Infant-with-suspected-Congenital-hypothyroidism-final.pdf ](https://pedsendo.org/wp-content/uploads/2020/09/Infant-with-suspected-Congenital-hypothyroidism-final.pdf) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ fda.report/DailyMed/B8FB4DCD-2531-40D3-BBFB-CCDC8CE327C4.pdf ](https://fda.report/DailyMed/B8FB4DCD-2531-40D3-BBFB-CCDC8CE327C4.pdf) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ van Trotsenburg ASP, et al. Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update. Thyroid. 2021. ](https://pmc.ncbi.nlm.nih.gov/articles/PMC8001676/) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ Health Resources and Services Administration. Congenital Hypothyroidism | Newborn Screening. Reviewed March 2026. ](https://newbornscreening.hrsa.gov/conditions/congenital-hypothyroidism) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ American College of Medical Genetics and Genomics. Newborn Screening ACT Sheet: Primary Congenital Hypothyroidism. Updated July 2024. ](https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Primary-TSH-ACT-Sheet.pdf) 9. 9. [ Pediatric Endocrine Society. Infant With Suspected Congenital Hypothyroidism. ](https://pedsendo.org/clinical-resource/infant-with-suspected-congenital-hypothyroidism/) 10. 10. [ DailyMed. Levothyroxine Sodium tablet label. ](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e5e81ae-8cd5-574d-e053-2995a90aaf4c) Next Practice Pediatrics the way boards test ----------------------------------------- - Age‑specific differentials and management - Growth, development, and immunizations - Target weak areas with smart review [ Start practicing ](https://mdster.com/user/dashboard) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. Explore topics: [ # Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ # Endocrinology ](https://mdster.com/blog?tag=endocrinology) [ # Newborn Screening ](https://mdster.com/blog?tag=newborn-screening) [ # Thyroid Disorders ](https://mdster.com/blog?tag=thyroid-disorders) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Multimodal Analgesia for Safer Postoperative Pain Plans 5 min read May 22, 2026 ](https://mdster.com/blog/multimodal-analgesia-for-safer-postoperative-pain-plans) [### Serotonin Syndrome and NMS Treatment in Emergency Medicine 5 min read May 21, 2026 ](https://mdster.com/blog/serotonin-syndrome-and-nms-treatment-in-emergency-medicine) [### HPA Axis and Cortisol Dynamics in Depression and PTSD 5 min read May 20, 2026 ](https://mdster.com/blog/hpa-axis-and-cortisol-dynamics-in-depression-and-ptsd) Related Posts ------------- [ ![Multimodal Analgesia for Safer Postoperative Pain Plans](https://mdster.com/storage/blog/images/multimodal-analgesia-for-safer-postoperative-pain-plans.jpg) Medical Education ### Multimodal Analgesia for Safer Postoperative Pain Plans Learn how to build safer postoperative multimodal analgesia plans using acetaminophen, NSAIDs, regional anesthesia, opioids, gabapentinoids, ketamine, and lidocaine. 5 min read 0 comments ](https://mdster.com/blog/multimodal-analgesia-for-safer-postoperative-pain-plans) [ ![Serotonin Syndrome and NMS Treatment in Emergency Medicine](https://mdster.com/storage/blog/images/serotonin-syndrome-and-nms-treatment-in-emergency-medicine.jpg) Medical Education ### Serotonin Syndrome and NMS Treatment in Emergency Medicine Treat serotonin syndrome and NMS with the right ED priorities: stop offending agents, use benzodiazepines, cool early, and know cyproheptadine’s limits. 5 min read 0 comments ](https://mdster.com/blog/serotonin-syndrome-and-nms-treatment-in-emergency-medicine) [ ![HPA Axis and Cortisol Dynamics in Depression and PTSD](https://mdster.com/storage/blog/images/hpa-axis-and-cortisol-dynamics-in-depression-and-ptsd.jpg) Medical Education ### HPA Axis and Cortisol Dynamics in Depression and PTSD Master HPA axis feedback loops, cortisol rhythms, depression hypercortisolemia, and PTSD cortisol patterns for clinical psychiatry and board exams. 5 min read 0 comments ](https://mdster.com/blog/hpa-axis-and-cortisol-dynamics-in-depression-and-ptsd) [ ![Eczema Herpeticum in Children: Emergency Case Discussion](https://mdster.com/storage/blog/images/eczema-herpeticum-in-children-emergency-case-discussion.jpg) Case Discussion ### Eczema Herpeticum in Children: Emergency Case Discussion A toxic toddler with atopic dermatitis and punched-out vesicles has eczema herpeticum until proven otherwise. Learn diagnosis, management, and board pearls. 5 min read 0 comments ](https://mdster.com/blog/eczema-herpeticum-in-children-emergency-case-discussion) [ ![Lower Genital Tract Lymphatics: Cervix and Vulva Drainage](https://mdster.com/storage/blog/images/lower-genital-tract-lymphatics-cervix-and-vulva-drainage.jpg) Medical Education ### Lower Genital Tract Lymphatics: Cervix and Vulva Drainage Master cervix and vulva lymphatic drainage patterns, including pelvic, obturator, iliac, and inguinal node spread in gynecologic malignancy. 4 min read 0 comments ](https://mdster.com/blog/lower-genital-tract-lymphatics-cervix-and-vulva-drainage) [ ![Initial Severity Assessment: Safe Disposition in Family Medicine](https://mdster.com/storage/blog/images/initial-severity-assessment-safe-disposition-in-family-medicine.jpg) Medical Education ### Initial Severity Assessment: Safe Disposition in Family Medicine A board-focused guide to deciding who is sick, who needs EMS or ED transfer, and who can be safely managed as an outpatient in family medicine. 2 min read 0 comments ](https://mdster.com/blog/initial-severity-assessment-safe-disposition-in-family-medicine) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept